Final Results From the Phase 2 Continuation Study of the Lenalidomide and Azacitidine Combination in Patients with Higher-Risk Myelodysplastic Syndromes (MDS) von Sekeres, Mikkael A., Komrokji, Rami S., Lancet, Jeffrey E., Tiu, Ramon V., Advani, Anjali S., Afable, Manual, Englehaupt, Ricki, Juersivich, Joyce, Cuthbertson, David, Paleveda, Jennifer, Paquette, Ronald, Smith, April, Strozniak, Lori, List, Alan F., Maciejewski, Jaroslaw P.

Volltext

A Proof of Principle Clinical Trial in Myelodysplastic Syndromes of Non-Cytotoxic Differentiation Therapy with Decitabine von Saunthararajah, Yogen, Mahfouz, Reda Z, Englehaupt, Ricki, Juersivich, Joy, Durkin, Lisa, Radivoyevitch, Tomas, Cooper, Kathleen, Afable, Manual, Dean, Robert, Advani, Anjali S., Kalaycio, Matt, Sobecks, Ronald, Copelan, Edward A., Hsi, Eric D., Maciejewski, Jaroslaw P., Sekeres, Mikkael A

Volltext

Prior Therapy with DNA Methyltransferase Inhibitors (DNMTI) Predicts for Lower Remission Rates and Worse Survival In Secondary Acute Myeloid Leukemia Patients (sAML) Receiving Remi... von Mohan, Sanjay R., Fu, Alex, Tiu, Ramon V., Copelan, Edward, Saunthararajah, Yogen, Advani, Anjali, Sobecks, Ronald, Afable, Manual, Englehaupt, Ricki, Paulic, Katarina, Earl, Marc, Kalaycio, Matt, Maciejewski, Jaroslaw P, Sekeres, Mikkael A.

Volltext

Final Results from a Phase I Combination Study of Lenalidomide and Azacitidine in Patients with Higher-Risk Myelodysplastic Syndromes (MDS) von Sekeres, Mikkael A., List, Alan F., Cuthbertson, David, Paquette, Ronald, Latham, Deborah, Afable, Manual, Paulic, Katarina, Loughran, Thomas P., Maciejewski, Jaroslaw P.

Volltext